PharmaTher plans U.S. network to 3D print medicines on demand

Canadian pharma company PharmaTher launched its M3DICINES National Network Program, a distributed network of sites that 3D print medicines closer to patients. It starts with U.S. compounding pharmacies and targets up to 50 Craft Health CraftMake printer installations over 12 months.

• Up to 50 CraftMake printer placements targeted in 12 months
• First site is PD Labs, PharmaTher's U.S. Center of Excellence
• CraftMake prints at room temperature without heat or UV light
• Network could supply medicines during shortages and emergencies